Q&I Director Vince Mor and colleagues published a paper in the September 2017 issue of Lancet Respiratory Medicine presenting the results of a cluster-randomized trial of high-dose influenza (flu) vaccine. They randomized more than 800 nursing centers to vaccinate their residents with either high- or standard-dose vaccine, and then examined hospitalization and other outcomes among residents in these facilities. Residents in centers randomized to receive high-dose flu vaccine had a lower risk of hospitalization for respiratory illness than residents in centers randomized to receive the standard-dose flu vaccine. These findings can inform nursing centers' decisions as they plan for future flu seasons.
High-dose flu vaccine reduces hospital visits for nursing center residents
